Showing results (1-10 of 431) with videos related to
Sort By:
Pageof 44
Future Oncology (London, England)|December 5, 2015
The evolving understanding of small HER2-positive breast cancers: matching management to outcomesAdrienne G Waks, Sara M TolaneyCurrent Treatment Options in Oncology|March 30, 2023
Individualizing Curative-Intent Therapy in HER2-Positive Early-Stage Breast CancerOlga Martínez-Sáez, Adrienne G WaksJournal of the National Comprehensive Cancer Network : JNCCN|March 10, 2016
Fertility Preservation in Patients With Breast Cancer: Necessity, Methods, and SafetyAdrienne G Waks, Ann H PartridgeBreast Cancer Research and Treatment|October 1, 2015
Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factorsAdrienne G Waks, Sara M Tolaney, Alicia Galar, et al.Breast (Edinburgh, Scotland)|October 22, 2011
Adjuvant chemotherapy in luminal breast cancersElgene Lim, Eric P WinerClinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 19, 2013
Trastuzumab emtansine: a novel antibody-drug conjugate for HER2-positive breast cancerIan Krop, Eric P WinerWomen'S Health (London, England)|October 7, 2009
Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early stage breast cancerJennifer A Ligibel, Eric P WinerBreast (Edinburgh, Scotland)|August 19, 2007
Follow-up care of patients with breast cancerSara M Tolaney, Eric P WinerJournal of the National Comprehensive Cancer Network : JNCCN|September 23, 2009
The aromatase inhibitors as adjuvant therapy for hormone receptor-positive breast cancerJennifer A Ligibel, Eric P WinerPageof 44